|
1. Indications And Usage Tracleer Is Indicated For The Treatment Of Pulmonary Arterial Hypertension (pah) (who Group 1): In Adults To Improve Exercise Ability And To Decrease Clinical Worsening. Studies Establishing Effectiveness Included Predominantly Patients With Who Functional Class Ii-Iv Symptoms And Etiologies Of Idiopathic Or Heritable Pah (60%), Pah Associated With Connective Tissue Diseases (21%), And Pah Associated With Congenital Heart Disease With Left-To-Right Shunts (18%) [see Clinical Studies (14.1) ] . In Pediatric Patients Aged 3 Years And Older With Idiopathic Or Congenital Pah To Improve Pulmonary Vascular Resistance (pvr), Which Is Expected To Result In An Improvement In Exercise Ability. Tracleer Is An Endothelin Receptor Antagonist Indicated For The Treatment Of Pulmonary Arterial Hypertension (pah) (who Group 1): In Adults To Improve Exercise Ability And To Decrease Clinical Worsening. Studies Establishing Effectiveness Included Predominantly Patients With Who Functional Class Ii-Iv Symptoms And Etiologies Of Idiopathic Or Heritable Pah (60%), Pah Associated With Connective Tissue Diseases (21%), And Pah Associated With Congenital Heart Disease With Left-To-Right Shunts (18%) ( 1 ). In Pediatric Patients Aged 3 Years And Older With Idiopathic Or Congenital Pah To Improve Pulmonary Vascular Resistance (pvr), Which Is Expected To Result In An Improvement In Exercise Ability ( 1 ).
|